"I see $RVVTF reaching $2 to $3 on clinical trial news or just before it.
I see the big boys like Goldman sucks and their high speed trading computers running this up $10 in the days of EUA FDA committee meetings and pre decision making, to do an offering at no less than $5/share to raise a pile of cash for RVVTF before any one knows what is cooking.
That will put a pile of serious cash into RVVTF for years as bid Support at $5/share
I think the big run starts in January. and breaks are least $3 in January, that is my educated guess."